Showing results (111-120 of 21,754) with videos related to
Sort By:
Pageof 2,176
British Journal of Cancer|July 29, 2010
A four-kallikrein panel for the prediction of repeat prostate biopsy: data from the European Randomized Study of Prostate Cancer screening in Rotterdam, NetherlandsA Gupta, M J Roobol, C J Savage, et al.British Journal of Cancer|July 29, 2010
Integrated preclinical and clinical development of mTOR inhibitors in pancreatic cancerI Garrido-Laguna, A C Tan, M Uson, et al.British Journal of Cancer|July 29, 2010
Integrated miRNA and mRNA expression profiling of the inflammatory breast cancer subtypeI Van der Auwera, R Limame, P van Dam, et al.British Journal of Cancer|July 29, 2010
BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy receivedS-J Dawson, N Makretsov, F M Blows, et al.British Journal of Cancer|August 19, 2010
Insulin-like growth factors and liver cancer risk in male smokersJ M Major, R Z Stolzenberg-Solomon, M N Pollak, et al.British Journal of Cancer|August 19, 2010
Activity and safety of NGR-hTNF, a selective vascular-targeting agent, in previously treated patients with advanced hepatocellular carcinomaA Santoro, T Pressiani, G Citterio, et al.British Journal of Cancer|August 19, 2010
Inactivation of the WASF3 gene in prostate cancer cells leads to suppression of tumorigenicity and metastasesY Teng, M Q Ren, R Cheney, et al.British Journal of Cancer|June 1, 1991
Monitoring therapeutic response to tamoxifen in NMU-induced rat mammary tumours by 31P MRSS Baluch, C J Midwood, J R Griffiths, et al.British Journal of Cancer|June 1, 1991
Cancer risk in second degree relatives of children with soft tissue sarcomaA L Hartley, J M Birch, M D Teare, et al.British Journal of Cancer|June 1, 1991
The effect of long acting somatostatin analogue SMS 201.995 therapy on tumour kinetic measurements and serum tumour marker concentrations in primary rectal cancerS Y Iftikhar, S A Watson, D L MorrisPageof 2,176